Business Description
Novartis AG is a Swiss pharmaceutical company founded in 1996 and headquartered in Basel, with operations spanning markets around the world. The company researches, develops, and sells a broad range of medicines targeting serious health conditions including heart disease, cancer, blood disorders, immune conditions, and neurological diseases. Its product portfolio includes well-known treatments such as Entresto for heart failure, Cosentyx for inflammatory conditions, Kisqali for breast cancer, and Zolgensma for spinal muscular atrophy, among many others. Novartis also works with outside partners, including a collaboration with Alnylam Pharmaceuticals to bring Leqvio to market as a cholesterol-lowering treatment.
